Diabetes Type 2

What is Diabetes Type 2?

Diabetes type 2 is a condition in which the body is resistant to insulin resulting in high blood sugar levels. Symptoms include fatigue, hunger, thirst, increased urination, and tingling in feet and hands.

Treatment for diabetes type 2 includes medication, diet, and exercise. Common drug classes used to treat diabetes type 2 are biguanides, insulins, sulfonylureas, gliptins, glitazones, sulfonylurea / biguanide combinations, gliptin / biguanide combinations, GLP-1 agonists, ergot derivatives, glinides, glitazone / biguanide combinations, alpha glucosidase inhibitors, amlyn analogues, glitazone / sulfonylurea combinations, gliptin / statin combinations, gliptin / glitazone combinations, SGLT2 inhibitors, and glinide / biguanide combinations.

Savings Tips for Diabetes Type 2

  • Byetta vs Bydureon: What’s the Difference?

    July 28, 2014

    Byetta (exenatide) and Bydureon (exenatide) for type 2 diabetes can be confusing—they have similar names, and both are injected rather than taken orally. However, there are advantages and disadvantages to each, and they are available in different strengths, and have different directions for use.

    What is type 2 diabetes?

    Type 2 diabetes, also known as adult onset diabetes, occurs when the body does not use the insulin it makes properly. See More

  • Levemir FlexPen Is Changing to Levemir FlexTouch

    July 02, 2014

    The delivery method of some drugs may be phased out or changed for a few reasons—sometimes a change might be required, like when CFC inhalers for asthma were found to be bad for the environment and replaced by the environmentally friendly HFA inhalers. Manufacturers may also find a better way to deliver their medication that makes it easier to use, and discontinue the older version.

    The latest medication to be phased out is the Levemir FlexPen. See More

  • Inhaled Insulin: Ten Things You Need to Know

    July 01, 2014

    The FDA just approved Afrezza, an inhaled insulin for both Type 1 and Type 2 diabetics. It will be available for prescription very soon, so will there be a run on it? Here are ten points to keep in mind.

      1.  The product will be called Afrezza and was developed by the MannKind Corporation.

      2.  It’s not the first time we’ve heard about inhaled insulin. Exubera, Pfizer’s attempt at inhaled insulin, was never popular because of a possible increase in lung cancer. See More

see all savings tips

Popular Diabetes Type 2 Drugs

Popularity Drug Name Drug Class Price
Glucophage
(metformin)
Biguanides 5 See Prices
Lantus Insulins 360 See Prices
Glucophage XR
(metformin er)
Biguanides 6 See Prices
see all 89 drugs

Note: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Diabetes Type 2 Drug Classes

Copyright ©2014 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks referenced are the trademarks of their respective owners. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.